We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The FDA’s Center for Drug Evaluation and Research (CDER) has released a draft technical document on how to use structured product labeling (SPL) Release 2, which incorporates changes in the requirements for the content and format of labeling for human prescription drug and biological products.